Literature DB >> 7030330

A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptides.

M Orlowski, S Wilk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030330     DOI: 10.1016/0006-291x(81)91823-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  17 in total

1.  Synthetic peptide-based activators of the proteasome.

Authors:  S Wilk; W E Chen
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

2.  A voyage to the inner space of cells.

Authors:  Wolfgang Baumeister
Journal:  Protein Sci       Date:  2005-01       Impact factor: 6.725

Review 3.  The proteasome: a central regulator of inflammation and macrophage function.

Authors:  Nilofer Qureshi; Stefanie N Vogel; Charles Van Way; Christopher J Papasian; Asaf A Qureshi; David C Morrison
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

Review 5.  Multicatalytic proteinase in fish muscle.

Authors:  J J Sánchez; E J Folco; L Busconi; C B Martone; C Studdert; C A Casalongué
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

Review 6.  The 20S/26S proteasomal pathway of protein degradation in muscle tissue.

Authors:  B Dahlmann; L Kuehn
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

7.  Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study.

Authors:  Siwei Zhang; Yawei Shi; Hongwei Jin; Zhenming Liu; Liangren Zhang; Lihe Zhang
Journal:  J Mol Model       Date:  2009-05-14       Impact factor: 1.810

8.  Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors.

Authors:  Deborah J Kuhn; Sally A Hunsucker; Qing Chen; Peter M Voorhees; Marian Orlowski; Robert Z Orlowski
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

9.  Membrane-bound enzymes and their role in processing of the dynorphins and of the proenkephalin octapeptide Metenkephalin-Arg-Gly-Leu.

Authors:  M Benuck; M J Berg; N Marks
Journal:  Neurochem Res       Date:  1984-06       Impact factor: 3.996

10.  Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.

Authors:  G L Powers; S J Ellison-Zelski; A J Casa; A V Lee; E T Alarid
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.